Paulina A García-González

A short protocol using dexamethasone and monophosphoryl lipid A generates tolerogenic dendritic cells that display a potent migratory capacity to lymphoid chemokines

Paulina A García-González, Rodrigo A. Morales, Lorena Hoyos et al. · Journal of Translational Medicine · 2013 · 43 citations · Full text

Dexamethasone and Monophosphoryl Lipid A Induce a Distinctive Profile on Monocyte-Derived Dendritic Cells through Transcriptional Modulation of Genes Associated With Essential Processes of the Immune Response

Paulina A García-González, Katina Schinnerling, Alejandro Sepúlveda-Gutiérrez et al. · Frontiers in Immunology · 2017 · 27 citations · Full text

Dysregulated Immune Responses in COVID-19 Patients Correlating With Disease Severity and Invasive Oxygen Requirements

Paulina A García-González, Fabián Tempio, Camila Fuentes et al. · Frontiers in Immunology · 2021 · 19 citations · Full text

Immune Regulation, Immunology, Severe Covid-19 Patients +19

Blocking of p38 and transforming growth factor β receptor pathways impairs the ability of tolerogenic dendritic cells to suppress murine arthritis

David Gárate, Nicole Rojas-Colonelli, Corina Peña et al. · Arthritis & Rheumatism · 2012 · 18 citations · Full text

Treatment with Dexamethasone and Monophosphoryl Lipid A Removes Disease-Associated Transcriptional Signatures in Monocyte-Derived Dendritic Cells from Rheumatoid Arthritis Patients and Confers Tolerogenic Features

Paulina A García-González, Katina Schinnerling, Alejandro Sepúlveda-Gutiérrez et al. · Frontiers in Immunology · 2016 · 16 citations · Full text